Study of Emergency Department Diagnosis Case Type Malpractice Claims: Abstract
A study of diagnosis-type closed medical malpractice claims from care that occurred in the ED from 2014 through the second quarter of 2019 using closed coded claims from The Doctors Company.
Search
April 04, 2022, Medical Economics
How the Tactics of Plaintiffs’ Lawyers Have Evolved
Robert E. White, Jr., Chief Operating Officer of The Doctors Company and TDC Group, explains that malpractice lawsuits now seek to punish wrongdoers, not just provide compensation to those harmed by malpractice.
The Doctors Company Announces $14.7 Million Dividend
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, announced today that it has approved a 2024 premium dividend of approximately $14.7 million, bringing the total of declared dividends to date to $470 million.
The Industry’s Strongest Malpractice Claims Defense
The Doctors Company is founded and led by physicians, which gives us a keen understanding of the impact of a malpractice claim. If a claim is ever made against you, we fight to win—both in and out of the courtroom.
Burnout and Litigation Against Primary Care Providers: Where Do They Overlap?
Certain trends in primary care suggest potential avenues for investigation into malpractice allegations. These include a worsening shortage of primary care physicians, an association between burnout and patient safety concerns, and the rise in both the number of women physicians and the rate of burnout among women physicians.
AM Best Affirms The Doctors Company’s ‘A’ Excellent Financial Rating
August 23, 2022: AM Best has affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and its long-term issuer credit rating (ICR) of "a+”. The outlook of these ratings is stable.
The Doctors Company Announces $8.5 Million Member Dividend
We are proud to announce The Doctors Company has approved a 2023 premium dividend of approximately $8.5 million, bringing the total of declared dividends to date to more than $455 million.
Informed Refusal
Documenting a patient’s refusal of test or treatment options is key to minimizing risk exposure.
Video Aug 29, 2025
How Will the Adoption of Artificial Intelligence (AI) in Healthcare Impact Industry Careers?
Robert M. Wachter, MD, Internist; Chair, Department of Medicine, UCSF; and Member, Board of Governors, The Doctors Company, presents at the 2025 TDC Group Executive Advisory Board Meeting about how artificial intelligence will affect the healthcare industry.
Video Oct 14, 2022
New Thinking About Primary Care and Practice Redesign
Megan Mahoney, MD, MBA, Professor and Chair of the UCSF Department of Family and Community Medicine and member of The Doctors Company Board of Governors, explains how she developed a new model for providing the most efficient and high-quality care in her practice.
